Bill · H.R. 1060· House(119-HR-1060)
Modern Authentication of Pharmaceuticals Act of 2025
- Introduced
- 2/6/2025
- Last activity
- 2/6/2025 — Referred to the House Committee on Energy and Commerce.
- Sponsored by
- Donald Davis
- Cosponsors
- - 0 - 3
- Introduced
- In Committee
What this bill would do
The Modern Authentication of Pharmaceuticals Act of 2025 aims to amend the Federal Food, Drug, and Cosmetic Act. It seeks to modernize how controlled substances are authenticated within the pharmaceutical distribution supply chain. The bill specifically introduces requirements for a physical chemical identifier for certain products. This applies to controlled substances that are in a solid oral dosage form. These requirements would apply to products manufactured on or after a date five years after the act's enactment.
Yes· 3 of 4
Does this do more about addiction and overdose deaths?+6
Modernizing the authentication of controlled substances can help prevent counterfeit drugs in the opioid crisis.
Does this give people more protection from unfair business practices?+5
The bill enhances consumer safety by ensuring the authenticity of controlled substances through physical identifiers.
Does this make health care easier to get in general?+3
By securing the drug supply chain, the bill indirectly supports safer healthcare access.
The opposite
Would business owners be better off under this?-2
Pharmaceutical manufacturers may face increased costs due to new authentication requirements.
Who it would affect, and how
Potential Positive Impacts for People
- Improved authentication of drugs: The bill introduces a physical chemical identifier that is in or on a product to authenticate the product or a dosage form (Section 2(a)(1) and Section 2(b)(1)(B)). This can be used to determine whether a product or a dosage form thereof is authentic (Section 2(b)(2)(B)).
Potential Negative Impacts for People
- No specific negative impacts are explicitly detailed in the text provided.
Groups and Interests Ranking
Every group the model scored this bill for, from -10 to +10. Hover a score for the reason it gave.
- Healthcare
- Improves Opioid Crisis Response+6Improves Healthcare Access+3
- Economy And Finance
- Improves Consumer Protection+5
- Demographic And Interest Groups
- Good For Business Owners-2
- Governance And Ideology
- Increases Federal Power+2
- 3/11/2025
- 1 Cosponsor added.
- 2/6/2025
- Sponsor introductory remarks on measure. (CR H519)
- Referred to the House Committee on Energy and Commerce.
- 2 Cosponsors added.
- Introduced in House
Don BaconRepublican · Nebraska
Brian FitzpatrickRepublican · Pennsylvania
John RutherfordRepublican · Florida